Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
Liu
G T
GT
Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL.
Kay
M D
MD
Byrne
G E
GE
Glaser
J S
JS
Schatz
N
N
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D002051:Burkitt Lymphoma / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D016027:Heart Transplantation; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008577:Meningeal Neoplasms / Q000150:complications* / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D015840:Oculomotor Nerve Diseases / Q000209:etiology*
D003561:Cytarabine; D003520:Cyclophosphamide; D008775:Methylprednisolone; D008727:Methotrexate